Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association
Vivek Bhalla(Ithaka Harbors), Gustavo S. Oderich(The University of Texas Health Science Center at Houston), Sanjay Misra(Mayo Clinic), Joshua A. Beckman(Clinical Research Institute), Esther Kim(Icahn School of Medicine at Mount Sinai), Christopher J. Cooper(University of Toledo), Stephen C. Textor(Textron Systems (United Kingdom)), Ana I. Casanegra(Mayo Clinic), James M. Luther(Vanderbilt University Medical Center)
Cited by 68
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
|Journal of the American College of Cardiology|2017|1.9k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
|European Journal of Vascular and Endovascular Surgery|2019|1.5k